A blister package of Ganaton<unk>  50 mg tablets intended for distribution in the Slovak Republic. Typically,<unk>  is indicated in the treatment of GI symptoms caused by reduced GI motility: *dyspepsia of a non-ulcer/dysmotility type (gastric "fullness", discomfort, and possible pain) *gastroparesis (delayed gastric emptying) *anorexia *heartburn *regurgitation *bloating *nausea and vomiting *other possible gastric, prolactin, or dopamine related conditions<unk>  was shown to significantly improve symptoms in patients with functional dyspepsia and motility disorders in placebo-controlled trials. These studies concluded that the reduction in the severity of symptoms of functional dyspepsia after 8 weeks of treatment with<unk>  indicated that<unk>  was significantly superior to placebo and that<unk>  yielded a greater rate of response than placebo in significantly reducing pain and fullness.
Itopride
Bromopride
Prucalopride
Tasimelteon
Cinitapride
Nyasol
Mitapivat
Icatibant